1 Market Overview
1.1 Pneumococcal Vaccine Polyvalent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumococcal Vaccine Polyvalent Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prevnar 13
1.2.3 Pneumovax23
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumococcal Vaccine Polyvalent Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 18 Years and Younger
1.3.3 19 To 64 Years Old
1.3.4 65 Years and Older
1.4 Global Pneumococcal Vaccine Polyvalent Market Size & Forecast
1.4.1 Global Pneumococcal Vaccine Polyvalent Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pneumococcal Vaccine Polyvalent Sales in Volume (2017-2028)
1.4.3 Global Pneumococcal Vaccine Polyvalent Price (2017-2028)
1.5 Global Pneumococcal Vaccine Polyvalent Production Capacity Analysis
1.5.1 Global Pneumococcal Vaccine Polyvalent Total Production Capacity (2017-2028)
1.5.2 Global Pneumococcal Vaccine Polyvalent Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pneumococcal Vaccine Polyvalent Market Drivers
1.6.2 Pneumococcal Vaccine Polyvalent Market Restraints
1.6.3 Pneumococcal Vaccine Polyvalent Trends Analysis
2 Manufacturers Profiles
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
2.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Pneumococcal Vaccine Polyvalent Product and Services
2.2.4 Pfizer Pneumococcal Vaccine Polyvalent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pneumococcal Vaccine Polyvalent Breakdown Data by Manufacturer
3.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pneumococcal Vaccine Polyvalent
3.4 Market Concentration Rate
3.4.1 Top 3 Pneumococcal Vaccine Polyvalent Manufacturer Market Share in 2021
3.4.2 Top 6 Pneumococcal Vaccine Polyvalent Manufacturer Market Share in 2021
3.5 Global Pneumococcal Vaccine Polyvalent Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pneumococcal Vaccine Polyvalent Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pneumococcal Vaccine Polyvalent Market Size by Region
4.1.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Region (2017-2028)
4.1.2 Global Pneumococcal Vaccine Polyvalent Revenue by Region (2017-2028)
4.2 North America Pneumococcal Vaccine Polyvalent Revenue (2017-2028)
4.3 Europe Pneumococcal Vaccine Polyvalent Revenue (2017-2028)
4.4 Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue (2017-2028)
4.5 South America Pneumococcal Vaccine Polyvalent Revenue (2017-2028)
4.6 Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Type (2017-2028)
5.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2017-2028)
5.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pneumococcal Vaccine Polyvalent Sales in Volume by Application (2017-2028)
6.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2017-2028)
6.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pneumococcal Vaccine Polyvalent Sales by Type (2017-2028)
7.2 North America Pneumococcal Vaccine Polyvalent Sales by Application (2017-2028)
7.3 North America Pneumococcal Vaccine Polyvalent Market Size by Country
7.3.1 North America Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2017-2028)
7.3.2 North America Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pneumococcal Vaccine Polyvalent Sales by Type (2017-2028)
8.2 Europe Pneumococcal Vaccine Polyvalent Sales by Application (2017-2028)
8.3 Europe Pneumococcal Vaccine Polyvalent Market Size by Country
8.3.1 Europe Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2017-2028)
8.3.2 Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2017-2028)
9.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2017-2028)
9.3 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Region
9.3.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pneumococcal Vaccine Polyvalent Sales by Type (2017-2028)
10.2 South America Pneumococcal Vaccine Polyvalent Sales by Application (2017-2028)
10.3 South America Pneumococcal Vaccine Polyvalent Market Size by Country
10.3.1 South America Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2017-2028)
10.3.2 South America Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type (2017-2028)
11.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application (2017-2028)
11.3 Middle East & Africa Pneumococcal Vaccine Polyvalent Market Size by Country
11.3.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pneumococcal Vaccine Polyvalent and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pneumococcal Vaccine Polyvalent
12.3 Pneumococcal Vaccine Polyvalent Production Process
12.4 Pneumococcal Vaccine Polyvalent Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pneumococcal Vaccine Polyvalent Typical Distributors
13.3 Pneumococcal Vaccine Polyvalent Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Pneumococcal Vaccine Polyvalent Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pneumococcal Vaccine Polyvalent Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
Table 6. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Pneumococcal Vaccine Polyvalent Product and Services
Table 10. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Pneumococcal Vaccine Polyvalent Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 12. Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Pneumococcal Vaccine Polyvalent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Pneumococcal Vaccine Polyvalent Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Pneumococcal Vaccine Polyvalent Production Site of Key Manufacturer
Table 16. Pneumococcal Vaccine Polyvalent New Entrant and Capacity Expansion Plans
Table 17. Pneumococcal Vaccine Polyvalent Mergers & Acquisitions in the Past Five Years
Table 18. Global Pneumococcal Vaccine Polyvalent Sales by Region (2017-2022) & (K Units)
Table 19. Global Pneumococcal Vaccine Polyvalent Sales by Region (2023-2028) & (K Units)
Table 20. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)
Table 23. Global Pneumococcal Vaccine Polyvalent Sales by Type (2023-2028) & (K Units)
Table 24. Global Pneumococcal Vaccine Polyvalent Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Pneumococcal Vaccine Polyvalent Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Pneumococcal Vaccine Polyvalent Price by Type (2017-2022) & (USD/Unit)
Table 27. Global Pneumococcal Vaccine Polyvalent Price by Type (2023-2028) & (USD/Unit)
Table 28. Global Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)
Table 29. Global Pneumococcal Vaccine Polyvalent Sales by Application (2023-2028) & (K Units)
Table 30. Global Pneumococcal Vaccine Polyvalent Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Pneumococcal Vaccine Polyvalent Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Pneumococcal Vaccine Polyvalent Price by Application (2017-2022) & (USD/Unit)
Table 33. Global Pneumococcal Vaccine Polyvalent Price by Application (2023-2028) & (USD/Unit)
Table 34. North America Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022) & (K Units)
Table 35. North America Pneumococcal Vaccine Polyvalent Sales by Country (2023-2028) & (K Units)
Table 36. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)
Table 39. North America Pneumococcal Vaccine Polyvalent Sales by Type (2023-2028) & (K Units)
Table 40. North America Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)
Table 41. North America Pneumococcal Vaccine Polyvalent Sales by Application (2023-2028) & (K Units)
Table 42. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022) & (K Units)
Table 43. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2023-2028) & (K Units)
Table 44. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)
Table 47. Europe Pneumococcal Vaccine Polyvalent Sales by Type (2023-2028) & (K Units)
Table 48. Europe Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)
Table 49. Europe Pneumococcal Vaccine Polyvalent Sales by Application (2023-2028) & (K Units)
Table 50. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2017-2022) & (K Units)
Table 51. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2023-2028) & (K Units)
Table 52. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)
Table 55. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Type (2023-2028) & (K Units)
Table 56. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)
Table 57. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales by Application (2023-2028) & (K Units)
Table 58. South America Pneumococcal Vaccine Polyvalent Sales by Country (2017-2022) & (K Units)
Table 59. South America Pneumococcal Vaccine Polyvalent Sales by Country (2023-2028) & (K Units)
Table 60. South America Pneumococcal Vaccine Polyvalent Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Pneumococcal Vaccine Polyvalent Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)
Table 63. South America Pneumococcal Vaccine Polyvalent Sales by Type (2023-2028) & (K Units)
Table 64. South America Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)
Table 65. South America Pneumococcal Vaccine Polyvalent Sales by Application (2023-2028) & (K Units)
Table 66. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Region (2017-2022) & (K Units)
Table 67. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Region (2023-2028) & (K Units)
Table 68. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type (2017-2022) & (K Units)
Table 71. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Type (2023-2028) & (K Units)
Table 72. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application (2017-2022) & (K Units)
Table 73. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales by Application (2023-2028) & (K Units)
Table 74. Pneumococcal Vaccine Polyvalent Raw Material
Table 75. Key Manufacturers of Pneumococcal Vaccine Polyvalent Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Pneumococcal Vaccine Polyvalent Typical Distributors
Table 79. Pneumococcal Vaccine Polyvalent Typical Customers
List of Figures
Figure 1. Pneumococcal Vaccine Polyvalent Picture
Figure 2. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type in 2021
Figure 3. Prevnar 13
Figure 4. Pneumovax23
Figure 5. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application in 2021
Figure 6. 18 Years and Younger
Figure 7. 19 To 64 Years Old
Figure 8. 65 Years and Older
Figure 9. Global Pneumococcal Vaccine Polyvalent Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Pneumococcal Vaccine Polyvalent Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Pneumococcal Vaccine Polyvalent Sales (2017-2028) & (K Units)
Figure 12. Global Pneumococcal Vaccine Polyvalent Price (2017-2028) & (USD/Unit)
Figure 13. Global Pneumococcal Vaccine Polyvalent Production Capacity (2017-2028) & (K Units)
Figure 14. Global Pneumococcal Vaccine Polyvalent Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Pneumococcal Vaccine Polyvalent Market Drivers
Figure 16. Pneumococcal Vaccine Polyvalent Market Restraints
Figure 17. Pneumococcal Vaccine Polyvalent Market Trends
Figure 18. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturer in 2021
Figure 19. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturer in 2021
Figure 20. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Pneumococcal Vaccine Polyvalent Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Pneumococcal Vaccine Polyvalent Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2017-2028)
Figure 24. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2017-2028)
Figure 25. North America Pneumococcal Vaccine Polyvalent Revenue (2017-2028) & (USD Million)
Figure 26. Europe Pneumococcal Vaccine Polyvalent Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue (2017-2028) & (USD Million)
Figure 28. South America Pneumococcal Vaccine Polyvalent Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue (2017-2028) & (USD Million)
Figure 30. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2028)
Figure 31. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2017-2028)
Figure 32. Global Pneumococcal Vaccine Polyvalent Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2028)
Figure 34. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2017-2028)
Figure 35. Global Pneumococcal Vaccine Polyvalent Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2028)
Figure 37. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2028)
Figure 38. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2017-2028)
Figure 39. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2017-2028)
Figure 40. United States Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2028)
Figure 44. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2028)
Figure 45. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2017-2028)
Figure 46. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2017-2028)
Figure 47. Germany Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2017-2028)
Figure 56. China Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2028)
Figure 63. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2028)
Figure 64. South America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2017-2028)
Figure 65. South America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Pneumococcal Vaccine Polyvalent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine Polyvalent in 2021
Figure 77. Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent
Figure 78. Pneumococcal Vaccine Polyvalent Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/